Newsletters and Deep Dive digital magazine
How to make it in the new normal
The new normal is already here. Get used to it.
Everything, from exercise classes to pub quizzes, went online last year – and medical education was no exception.
Early data indications from the first virtual congresses shows big changes are needed.
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.